Aptevo Therapeutics (APVO) Other Non Operating Income (2015 - 2026)
Aptevo Therapeutics (APVO) posted Other Non Operating Income of $140000.0 for Q1 2026, down 26.32% sequentially from $190000.0 in Q4 2025, and up 94.44% YoY from $72000.0 in Q1 2025.
Aptevo Therapeutics (APVO) Other Non Operating Income (2015 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Other Non Operating Income for 12 years, with the latest figure at $140000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 94.44% year-over-year to $140000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $413000.0 (up 4.56% YoY) and the FY2025 annual result came in at $345000.0, down 26.91% from the prior year.
- Other Non Operating Income slipped to $140000.0 in Q1 2026 per APVO's latest filing, from $190000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $39.4 million in Q2 2022 and troughed at -$41.2 million in Q4 2022.
- A 5-year average of -$148058.8 and a median of $112000.0 in 2024 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 1784.29% in 2022, down 1511.62% in 2022.
- Over 5 years, Other Non Operating Income stood at -$41.2 million in 2022, then surged by 100.46% to $188000.0 in 2023, then sank by 62.77% to $70000.0 in 2024, then surged by 171.43% to $190000.0 in 2025, then declined by 26.32% to $140000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $140000.0, $190000.0, and $61000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 227,000.00 |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | -67,000.00 |
| Dec 31, 2022 | -41.21 Mn |
| Sep 30, 2022 | -25,000.00 |
| Jun 30, 2022 | 39.45 Mn |
| Mar 31, 2022 | -2.26 Mn |
| Dec 31, 2021 | -2.56 Mn |
| Sep 30, 2021 | -2.33 Mn |